Carmed Pharmaceuticals, a Turkey-based company specializing in standardized carvacrol-based formulations, announced plans to expand its U.S. distribution with an upcoming launch on OneLavi, a curated online marketplace for beauty, health, and wellness products. The move is part of Carmed’s broader strategy to increase accessibility to its research-driven formulations while building long-term credibility in the American market.
OneLavi provides a selective environment where brands are positioned alongside premium wellness offerings, allowing Carmed to introduce its formulations within a more focused consumer experience. “Expanding onto OneLavi allows us to introduce our formulations in a curated environment where quality and product integrity are prioritized,” said Mustafa Can, Founder of Carmed Pharmaceuticals. “This aligns with our commitment to standardized development and consistent formulation quality.”
As part of its OneLavi launch, Carmed plans to introduce several core formulations, including Vacrol® Kids Spray, S-Mix®, Vacrol® Capsule, Vacrol-M® Capsule, and Omevaq-3®. Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.
Carmed’s approach integrates traditional botanical knowledge with modern pharmaceutical methodology to develop standardized formulations designed to support immune resilience, cellular health, and overall physiological balance. The company emphasizes that its formulations are developed using standardized processes to ensure consistency, reproducibility, and quality control across production.
In January 2026, a study published in the peer-reviewed journal Plants examined Vacrol® and S-Mix® in preclinical laboratory and in ovo models, contributing to the broader scientific investigation of carvacrol-based formulations. The company notes that this research reflects scientific investigation into formulation science and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.
“The OneLavi launch is an important step in building awareness and accessibility for Carmed in the United States,” said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. “We are focused on introducing our formulations to new audiences while maintaining the same standards of quality, consistency, and research-driven development.”
Carmed Pharmaceuticals, officially established in 2019 following years of research and development, operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards. Availability timelines and product listings on OneLavi will be announced in the coming weeks.
